IP6K1 activators are a class of chemicals specifically designed to upregulate the activity of inositol hexakisphosphate kinase 1 (IP6K1), an enzyme that is responsible for the phosphorylation of inositol hexakisphosphate (IP6) to produce inositol pyrophosphate (IP7). IP6K1 is one of several kinases that play a central role in cellular metabolism, by being involved in the synthesis of a unique set of high-energy inositol pyrophosphates. These molecules are known to participate in a wide array of cellular functions, including energy homeostasis, DNA repair, and signal transduction, by acting as secondary messengers. Activators of IP6K1 are therefore small molecules that interact with the enzyme to enhance its catalytic efficiency, stabilize its active form, or increase its affinity for substrates. The chemical design of these activators often takes advantage of the enzyme's active site architecture, substrate specificity, and allosteric sites to ensure precise targeting and a high degree of specificity for IP6K1.
The synthesis and refinement of IP6K1 activators involve a sophisticated understanding of the enzyme's structure and kinetics. Since the active site of IP6K1 is where the enzyme binds its substrate and carries out the transfer of a phosphate group, activators are crafted to fit within this site or to interact with regions of the enzyme that can induce a conformational change, leading to increased activity. Computational chemistry and structure-based drug design play significant roles in this process, as they allow for the virtual screening of potential activators and the prediction of their interactions with IP6K1. Through iterative cycles of design, synthesis, and biological evaluation, researchers work to optimize these molecules for greater potency and selectivity. Additionally, the study of IP6K1 activators frequently involves the use of various biochemical assays to characterize the kinetics of enzyme activation and to understand the molecular basis of the interaction between the enzyme and the activator.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium Butyrate could potentially stimulate IP6K1 expression. As an HDAC inhibitor, it could enhance the transcription of IP6K1 by changing the chromatin structure, making the gene more accessible for transcription machinery. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine might induce the expression of IP6K1. It's a demethylating agent that reduces DNA methylation, potentially increasing gene transcription by making the DNA more accessible to the transcriptional machinery. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol might stimulate the transcription of IP6K1. By activating sirtuins, proteins involved in regulating transcription, it might indirectly lead to an increase in IP6K1 expression. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
Dexamethasone could potentially augment IP6K1 expression. As a glucocorticoid, it may modulate transcription factors that regulate IP6K1, leading to enhanced gene expression. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic Acid, a metabolite of Vitamin A, is known to regulate gene expression. It might potentially induce an increase in the transcription of IP6K1. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium Chloride could potentially stimulate IP6K1 expression. By inhibiting GSK3β, a kinase involved in various cellular processes, it might indirectly lead to an increase in IP6K1 expression. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin might enhance IP6K1 expression. By activating adenylate cyclase and increasing cAMP levels, it could modulate transcription factors that regulate IP6K1. | ||||||
Metformin-d6, Hydrochloride | 1185166-01-1 | sc-218701 sc-218701A sc-218701B | 1 mg 5 mg 10 mg | $292.00 $822.00 $1540.00 | 1 | |
Metformin, by activating AMPK, could potentially enhance IP6K1 expression. AMPK regulates cellular energy homeostasis, and its activation could potentially alter various signaling pathways leading to increased IP6K1 expression. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin could potentially stimulate IP6K1 expression. It is known to modulate numerous signaling pathways, and by influencing these pathways, it could lead to an increase in IP6K1 expression. | ||||||